Irvine Scientific, a pioneer in developing products specifically for the Assisted Reproductive Technology (ART) community, announced that the U.S. Food and Drug Administration (FDA) has approved their products intended for vitrification of pronuclear (PN) zygotes through day 3 cleavage and blastocyst stage embryos within the fertility area...
More...
More...